Lymphomed Pharma Private Limited
About Lymphomed Pharma Private Limited
Data last updated:
Lymphomed Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC331736. Its GSTIN is 07AADCL5667Q1ZQ (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Juhi Kumari and Prabhat Kumar Singh.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at F 90/33 Okhla Phase – 1 Okhla Industrial Area, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2021, the company reported a revenue of ₹73,997. For the same year it recorded a net loss of ₹22,551 (net margin -30.5%) and EBITDA of -₹22,551 (EBITDA margin -30.5%).
Company details
Contact details
Lymphomed Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF 90/33 Okhla Phase – 1 Okhla Industrial Area, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Lymphomed Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lymphomed Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Lymphomed Pharma Private Limited, buy the company report.
Financials of Lymphomed Pharma Private Limited
FY 2021 filings availableLymphomed Pharma Private Limited reported revenue of ₹73,997 for FY 2021.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹22,551 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹22,551 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -30.5% | |||
| Net Profit Margin | -30.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Lymphomed Pharma Private Limited, buy the company report.
Board of directors of Lymphomed Pharma Private Limited
Lymphomed Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Juhi Kumari | Director | 02 Nov 2018 | 8 Years 0 Months | Current |
| Prabhat Kumar Singh | Director | 28 Mar 2018 | 8 Years 7 Months | Current |
| Lal Ratnakar | Director | 28 Mar 2018 | 8 Years 7 Months | Current |
Peer comparison
Lymphomed Pharma Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shining Medicos (OPC) Private Limited | ₹74,125 (FY 2025) | -80.0% | Gopalganj, Bihar, India | |||
| Zoistro Technologies Private Limited | ₹74,061 (FY 2021) | -1.0% | Bangalore, Karnataka, India | |||
| Creciente Maquillage Private Limited | ₹74,002 (FY 2021) | New Delhi, Delhi, India | ||||
| Willpower Daily Care India Limited | ₹74,000 (FY 2020) | 231.0% | Mumbai, Maharashtra, India | |||
| Sim Devcon Private Limited | ₹74,000 (FY 2025) | 29.0% | Kolkata, West Bengal, India | |||
| Lymphomed Pharma Private Limitedthis company | ₹73,997 (FY 2021) | -₹22,551 | -30.5% | New Delhi, Delhi, India | ||
| Pioneer Vinimay Private Limited | ₹73,965 (FY 2018) | -50.0% | Kolkata, West Bengal, India | |||
| Earthcode Private Limited | ₹73,921 (FY 2025) | -42.0% | Shamli, Uttar Pradesh, India | |||
| Chawla Lights & Appliances Pvt Ltd | ₹73,886 (FY 2025) | 1169.0% | Kolkata, West Bengal, India | |||
| Dasplore Mercantile Private Limited | ₹73,832 (FY 2021) | Bhubaneswar, Odisha, India |
To see the full peer comparison of Lymphomed Pharma Private Limited, buy the company report.
Auditor
Lymphomed Pharma Private Limited is audited by R S V K & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R S V K & ASSOCIATES | FY 2019 | 030089N |
Shareholding
The shareholding of Lymphomed Pharma Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Lymphomed Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lymphomed Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lymphomed Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lymphomed Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCL5667Q1ZQ | Delhi | Active | 02 May 2018 |
To see the full GST registrations and return filing status of Lymphomed Pharma Private Limited, buy the company report.
Recent activity
Lymphomed Pharma Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Juhi Kumari was appointed as Director on 02 Nov 2018.
Frequently asked questions
Lymphomed Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 March 2018 (8+ years old) and is registered under CIN U74999DL2018PTC331736.
Lymphomed Pharma has 3 current directors:
- Juhi Kumari - Director
- Prabhat Kumar Singh - Director
- Lal Ratnakar - Director
The latest financial statements of Lymphomed Pharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Lymphomed Pharma is 07AADCL5667Q1ZQ, registered in Delhi.
The CIN (Corporate Identification Number) of Lymphomed Pharma is U74999DL2018PTC331736. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lymphomed Pharma was incorporated on 28 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Lymphomed Pharma by revenue are Shining Medicos (OPC) Private Limited, Zoistro Technologies Private Limited, Creciente Maquillage Private Limited, Willpower Daily Care India Limited, Sim Devcon Private Limited and 4 more, all in the same principal business activity (retail trading).
Juhi Kumari was appointed as Director on 02 Nov 2018. Lal Ratnakar was appointed as Director on 28 Mar 2018. Prabhat Kumar Singh was appointed as Director on 28 Mar 2018.
The registered office of Lymphomed Pharma is at F 9033 Okhla Phase – 1 Okhla Industrial Area, New Delhi, Delhi, India – 110020.
Lymphomed Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Lymphomed Pharma can be reached at its registered office: F 9033 Okhla Phase – 1 Okhla Industrial Area, New Delhi, Delhi, India – 110020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
